Where do we go from here ?We are now into March and we all agree what will move the stock to the next level: delivery of the Dermal Injector test units.
So the next question is: when will we see this happen?
The share price has flatlined this past few days with low volume. Would have liked to see this flatline above $.60 at this point but I guess it's better than $.25. My fear is that the "johnny come lately" group will grow impatient and begin to flog their shares.
Now that Mainpointe has paid the first tranche of $500,000 it should get things moving. That is if money was an issue in getting the production done on these first test units.
As usual the company is not to forthcoming with any information regarding these devices.